About 60 Percent of PCI Patients Referred to Cardiac Rehab

Share this content:
About 60 Percent of PCI Patients Referred to Cardiac Rehab
About 60 Percent of PCI Patients Referred to Cardiac Rehab

TUESDAY, May 12, 2015 (HealthDay News) -- Cardiac rehabilitation referral rates are about 60 percent for U.S. patients undergoing percutaneous coronary intervention (PCI), with considerable site-specific variation in rates of referral, according to a study published in the May 19 issue of the Journal of the American College of Cardiology.

Krishna G. Aragam, M.D., from Massachusetts General Hospital in Boston, and colleagues examined the prevalence of and factors associated with referral to cardiac rehabilitation in a national PCI cohort. Data were included for 1,432,399 patients who underwent PCI at 1,310 participating hospitals.

The researchers found that cardiac rehabilitation referral rates were 59.2 percent for the overall population and 66.0 percent for the subgroup of Medicare patients presenting with acute myocardial infarction. Presentation with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction correlated with elevated odds of referral to cardiac rehabilitation (odds ratios, 2.99 and 1.99, respectively), in multivariable analyses. After adjustment for insurance status, there was significant site-specific variability in referral rates, with more than 25 percent of all hospitals referring fewer than 20 percent of patients.

"These findings highlight the potential need for hospital-level interventions to improve cardiac rehabilitation referral rates after PCI," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »